Effect of Olopatadine (cas 113806-05-6)-mometasone combination nasal spray on seasonal allergic rhinitis symptoms in an environmental exposure chamber study
-
Add time:08/27/2019 Source:sciencedirect.com
BackgroundGSP301 nasal spray is a fixed-dose combination of the antihistamine olopatadine hydrochloride and the corticosteroid mometasone furoate intended for seasonal allergic rhinitis (SAR) treatment.
We also recommend Trading Suppliers and Manufacturers of Olopatadine (cas 113806-05-6). Pls Click Website Link as below: cas 113806-05-6 suppliers
Prev:Olopatadine (cas 113806-05-6) hydrochloride loaded Kollidon® SR nanoparticles for ocular delivery: Nanosuspension formulation and in vitro–in vivo evaluation
Next:Immunopharmacology and inflammationOlopatadine (cas 113806-05-6) hydrochloride suppresses hot flashes induced by topical treatment with tacrolimus ointment in rats) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- The antihistamine Olopatadine (cas 113806-05-6) regulates T cell activation in palladium allergy08/29/2019
- Immunopharmacology and inflammationOlopatadine (cas 113806-05-6) hydrochloride suppresses hot flashes induced by topical treatment with tacrolimus ointment in rats08/28/2019
- Olopatadine (cas 113806-05-6) hydrochloride loaded Kollidon® SR nanoparticles for ocular delivery: Nanosuspension formulation and in vitro–in vivo evaluation08/26/2019
- Full length articleBiomimetic contact lenses eluting Olopatadine (cas 113806-05-6) for allergic conjunctivitis☆08/25/2019
- Olopatadine (cas 113806-05-6) enhances recovery of alkali-induced corneal injury in rats08/24/2019
- Original ArticleEfficacy and safety of Olopatadine (cas 113806-05-6)-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis08/23/2019
- Poly (vinyl chloride) matrix membrane sensors for the quantification of Olopatadine (cas 113806-05-6) and oxeladine in pharmaceutical preparations and human plasma08/22/2019
